Fund Holdings — Octagon Capital Advisors LP

Total Portfolio Value
$606.10M
Total Bought
$144.12M
Total Sold
$210.78M
Net Transaction
-$66.67M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q1 2024
▲▼
Q2 2024
▲▼
Change
▲▼
Q1 2024
▲▼
Q2 2024
▲▼
Weight (%)
▲▼
Change
▲▼
STRUCTURE THERAPEUTICS INC506,6041,140,060+633,45621,71344,7707.39%+23,057
PERSPECTIVE THERAPEUTICS INC(CATX)01,580,249+1,580,249015,7552.60%+15,755
INSMED INC(INSM)1,140,000650,216-489,78430,92843,5647.19%+12,636
REGULUS THERAPEUTICS INC04,263,701+4,263,70107,6111.26%+7,611
DYNE THERAPEUTICS INC(DYN)1,242,9451,180,798-62,14735,28741,6706.88%+6,383
CORBUS PHARMACEUTICALS HLDGS(CRBP)405,000488,000+83,00015,89222,0823.64%+6,190
TERNS PHARMACEUTICALS INC625,0001,364,400+739,4004,1009,2921.53%+5,192
ALLOVIR INC4,200,0009,800,000+5,600,0003,1717,0881.17%+3,918
DIANTHUS THERAPEUTICS INC(DNTH)1,380,6671,746,667+366,00041,42045,2047.46%+3,784
AN2 THERAPEUTICS INC1,103,0003,220,263+2,117,2633,5856,9241.14%+3,339
ELEVATION ONCOLOGY INC0747,000+747,00002,0170.33%+2,017
TAYSHA GENE THERAPIES INC(TSHA)3,030,0004,572,222+1,542,2228,69610,2421.69%+1,546
CENTURY THERAPEUTICS INC(IPSC)540,0001,333,650+793,6502,2573,4010.56%+1,144
PEPGEN INC(PEPG)376,117376,11705,5296,0030.99%+474
HELIX ACQUISITION CORP II250,000250,00002,5882,5550.42%-32
MINERALYS THERAPEUTICS INC(MLYS)550,000600,000+50,0007,1017,0201.16%-80
POSEIDA THERAPEUTICS INC736,000736,00002,3482,1490.35%-199
RENEO PHARMACEUTICALS INC2,250,0002,250,00003,7353,3980.56%-337
AUTOLUS THERAPEUTICS PLC(AUTL)176,000176,00001,1236120.10%-510
ADICET BIO INC767,799767,79901,8049290.15%-875
CABALETTA BIO INC(CABA)52,0000-52,0008870—-887
NKARTA INC(NKTX)240,000240,00002,5941,4180.23%-1,176
ARRIVENT BIOPHARMA INC(AVBP)1,943,8361,803,304-140,53234,71733,4515.52%-1,266
ATYR PHARMA INC700,0000-700,0001,3650—-1,365
RAPT THERAPEUTICS INC292,000292,00002,6228910.15%-1,732
AKERO THERAPEUTICS INC340,000283,372-56,6288,5886,6481.10%-1,940
CENTESSA PHARMACEUTICALS PLC2,060,1002,345,075+284,97523,27921,1763.49%-2,103
FATE THERAPEUTICS INC(FATE)520,800520,80003,8231,7080.28%-2,114
MERSANA THERAPEUTICS INC1,000,000992,000-8,0004,4801,9940.33%-2,486
GOSSAMER BIO INC(GOSS)9,187,8839,187,883010,8428,2771.37%-2,564
CYBIN INC(HELP)18,604,65018,604,65007,6935,0420.83%-2,651
VERU INC(VERU)3,800,0000-3,800,0002,6600—-2,660
VENTYX BIOSCIENCES INC1,501,1142,391,114+890,0008,2565,5230.91%-2,733
VIRIDIAN THERAPEUTICS INC(VRDN)620,000620,000010,8568,0661.33%-2,790
ALLOGENE THERAPEUTICS INC720,0000-720,0003,2180—-3,218
SILENCE THERAPEUTICS PLC(SLN)315,000176,000-139,0006,8043,3440.55%-3,460
SANA BIOTECHNOLOGY INC(SANA)360,8000-360,8003,6080—-3,608
ANAPTYSBIO INC165,0000-165,0003,7160—-3,716
NUVATION BIO INC(NUVB)1,374,870431,600-943,2705,0051,2600.21%-3,744
BRIDGEBIO PHARMA INC(BBIO)690,000690,000021,33517,4782.88%-3,857
MIND MEDICINE MINDMED INC2,153,0002,153,000020,23815,5232.56%-4,715
PHATHOM PHARMACEUTICALS INC(PHAT)455,0000-455,0004,8320—-4,832
VINCERX PHARMA INC1,000,0000-1,000,0005,0600—-5,060
PRAXIS PRECISION MEDICINES I(PRAX)260,000260,000015,86510,7541.77%-5,112
OCULAR THERAPEUTIX INC(OCUL)2,425,0002,425,000022,06816,5872.74%-5,480
TENAYA THERAPEUTICS INC(TNYA)2,854,0002,576,200-277,80014,9267,9861.32%-6,940
ARROWHEAD PHARMACEUTICALS IN(ARWR)250,0000-250,0007,1500—-7,150
JASPER THERAPEUTICS INC(JSPR)500,811287,500-213,31114,7046,5261.08%-8,178
IMMUNOVANT INC(IMVT)273,2890-273,2898,8300—-8,830
GLYCOMIMETICS INC3,000,0000-3,000,0009,0000—-9,000
NEWAMSTERDAM PHARMA COMPANY
ORDINARY SHARES
408,0000-408,0009,6490—-9,649
VERONA PHARMA PLC2,369,0001,895,200-473,80038,11727,4054.52%-10,713
AEROVATE THERAPEUTICS INC403,685465,440+61,75511,9377730.13%-11,164
ANNEXON INC(ANNX)2,050,000400,000-1,650,00014,6991,9600.32%-12,738
EYEPOINT PHARMACEUTICALS INC(EYPT)1,093,5031,093,503022,6039,5131.57%-13,089
CYTOKINETICS INC(CYTK)194,0000-194,00013,6010—-13,601
PERSPECTIVE THERAPEUTICS INC(CATX)14,718,4220-14,718,42217,5150—-17,515
ALPINE IMMUNE SCIENCES INC1,241,3000-1,241,30049,2050—-49,205
APELLIS PHARMACEUTICALS INC
COM
2,806,9802,880,880+73,900164,994110,51118.23%-54,484
Page 1 of 1
Octagon Capital Advisors LP — 13F Holdings — Q2 2024 | TickerTrail